Amy C. Peterson - Net Worth and Insider Trading
Amy C. Peterson Net Worth
The estimated net worth of Amy C. Peterson is at least $32 Million dollars as of 2024-05-06. Amy C. Peterson is the CMO, Immuno-oncology of BeiGene Ltd and owns about 194,569 shares of BeiGene Ltd (BGNE) stock worth over $32 Million. Amy C. Peterson is also the EVP, Chief Development Officer of CytomX Therapeutics Inc and owns about 58,433 shares of CytomX Therapeutics Inc (CTMX) stock worth over $258,858. Details can be seen in Amy C. Peterson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amy C. Peterson has not made any transactions after 2023-03-16 and currently still holds the listed stock(s).
Transaction Summary of Amy C. Peterson
Amy C. Peterson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy C. Peterson owns 3 companies in total, including CytomX Therapeutics Inc (CTMX) , BeiGene Ltd (BGNE) , and Exelixis Inc (EXEL) .
Click here to see the complete history of Amy C. Peterson’s form 4 insider trades.
Insider Ownership Summary of Amy C. Peterson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CTMX | CytomX Therapeutics Inc | 2023-03-16 | EVP & Chief Development Officer |
BGNE | BeiGene Ltd | 2018-12-18 | CMO & Immuno-oncology |
EXEL | Exelixis Inc | 2023-08-24 | EVP Prod Dev & Med Aff & CMO |
Amy C. Peterson Latest Holdings Summary
Amy C. Peterson currently owns a total of 2 stocks. Among these stocks, Amy C. Peterson owns 194,569 shares of BeiGene Ltd (BGNE) as of December 18, 2018, with a value of $32 Million and a weighting of 99.19%. Amy C. Peterson also owns 58,433 shares of CytomX Therapeutics Inc (CTMX) as of March 16, 2023, with a value of $258,858 and a weighting of 0.81%.
Latest Holdings of Amy C. Peterson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BGNE | BeiGene Ltd | 2018-12-18 | 194,569 | 162.25 | 31,568,820 |
CTMX | CytomX Therapeutics Inc | 2023-03-16 | 58,433 | 4.43 | 258,858 |
Holding Weightings of Amy C. Peterson
Amy C. Peterson Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy C. Peterson has made a total of 0 transactions in BeiGene Ltd (BGNE) over the past 5 years. The most-recent trade in BeiGene Ltd is the sale of 20,000 shares on December 18, 2018, which brought Amy C. Peterson around $3 Million.
According to the SEC Form 4 filings, Amy C. Peterson has made a total of 2 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 4,257 shares on March 16, 2023, which brought Amy C. Peterson around $8,429.
Insider Trading History of Amy C. Peterson
- 1
Amy C. Peterson Trading Performance
Amy C. Peterson Ownership Network
Ownership Network List of Amy C. Peterson
Ownership Network Relation of Amy C. Peterson
Amy C. Peterson Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Amy C. Peterson is the EVP & Chief Development Officer of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Amy C. Peterson made 1 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 4,257. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Amy C. Peterson Mailing Address
Above is the net worth, insider trading, and ownership report for Amy C. Peterson. You might contact Amy C. Peterson via mailing address: C/o Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman E9 Ky1-1108.